ADPT Competitors & Alternatives
Compare Adaptive Biotechnologies Corp with similar stocks in the same industry
Diagnostics & Research
ADPT
Main Stock$24.20
Tradestie Score
55
Market Cap
$2.22B
Revenue Growth
0.2%
Analyst Upside
+3.6%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RDNT
RadNet, Inc. Common Stock
|
$75.49
|
$6.00B | - | 61 | Compare |
|
BLLN
BLLN
|
$98.77
|
$4.65B | 138.7 | 48 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$18.37
|
$4.60B | 32.0 | 46 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$85.27
|
$3.26B | - | 36 | Compare |
|
VCYT
Veracyte, Inc.
|
$40.87
|
$2.85B | 31.4 | 52 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$23.99
|
$2.44B | - | 37 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$76.23
|
$2.24B | - | 49 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$127.22
|
$1.77B | - | 46 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$68.59
|
$1.54B | - | 52 | Compare |
|
NEOG
Neogen Corp
|
$11.78
|
$1.26B | - | 46 | Compare |
More ADPT Analysis
Data updated: Sep 11, 2026 | Industry: Diagnostics & Research (SIC 2836)
36 stocks in this industry